ReP USP - Resultado da busca

Filtros : "Indexado no SCOPUS" "Berman, David M." Limpar

Filtros

USP affiliated authors
- reis, rodolfo borges dos (2)
- squire, jeremy andrew (2)
- albuquerque, clarissa gondim picanço de (1)
- chesca, deise lucia (1)
- saggioro, fabiano pinto (1)

Indexado em
- indexado no embase (2)
- indexado no medline (2)
- indexado no pubmed (2)
- indexado no scopus (2)
- indexado no web of science (2)

Collaboration
Normalized affiliation
Non normalized affiliation
- cancer biology and genetics, queen's cancer research institute, queen's university, kingston (1)
- department of biomedical and molecular sciences, queen's university, kingston (1)
- department of genetics, ribeirão preto medical school, university of são paulo, ribeirão preto (1)
- department of pathology and molecular medicine, queen's university, kingston (1)
- department of pathology, johns hopkins university, baltimore (1)

Artigo de periodico
Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN) (2020)
Jamaspishvili, Tamara; Patel, Palak G; Niu, Yi; Vidotto, Thiago; Caven, Isabelle; Livergant, Rachel; Fu, Winnie; Kawashima, Atsunari; How, Nathan; Okello, John B.; Guedes, Liana B.; Ouellet, Veronique; Picanço, Clarissa; Koti, Madhuri; Reis, Rodolfo Borges dos ; Saad, Fred; Mes-Masson, Anne-Marie; Lotan, Tamara L; Squire, Jeremy Andrew ; Peng, Yingwei P.; Siemens, D. Robert; Berman, David M.
Source: JNCI: Journal of the National Cancer Institute. Unidade: FMRP
Subjects: PRÓSTATA, NEOPLASIAS, PROSTATECTOMIA, IMUNOHISTOQUÍMICA, ANÁLISE EM MICROSSÉRIES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JAMASPISHVILI, Tamara et al. Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN). JNCI: Journal of the National Cancer Institute, v. 112, n. 11, p. 1098-1104, 2020Tradução . . Disponível em: https://doi.org/10.1093/jnci/djaa032. Acesso em: 10 nov. 2024.
APA
Jamaspishvili, T., Patel, P. G., Niu, Y., Vidotto, T., Caven, I., Livergant, R., et al. (2020). Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN). JNCI: Journal of the National Cancer Institute, 112( 11), 1098-1104. doi:10.1093/jnci/djaa032
NLM
Jamaspishvili T, Patel PG, Niu Y, Vidotto T, Caven I, Livergant R, Fu W, Kawashima A, How N, Okello JB, Guedes LB, Ouellet V, Picanço C, Koti M, Reis RB dos, Saad F, Mes-Masson A-M, Lotan TL, Squire JA, Peng YP, Siemens DR, Berman DM. Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN) [Internet]. JNCI: Journal of the National Cancer Institute. 2020 ; 112( 11): 1098-1104.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/jnci/djaa032
Vancouver
Jamaspishvili T, Patel PG, Niu Y, Vidotto T, Caven I, Livergant R, Fu W, Kawashima A, How N, Okello JB, Guedes LB, Ouellet V, Picanço C, Koti M, Reis RB dos, Saad F, Mes-Masson A-M, Lotan TL, Squire JA, Peng YP, Siemens DR, Berman DM. Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN) [Internet]. JNCI: Journal of the National Cancer Institute. 2020 ; 112( 11): 1098-1104.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/jnci/djaa032
Artigo de periodico
PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells (2019)
Vidotto, Thiago ; Saggioro, Fabiano Pinto ; Jamaspishvili, Tamara; Chesca, Deise Lúcia; Albuquerque, Clarissa Gondim Picanço de; Reis, Rodolfo Borges dos ; Graham, Charles H.; Berman, David M.; Siemens, D. Robert; Squire, Jeremy Andrew ; Koti, Madhuri
Source: The Prostate. Unidades: SVOI, FMRP
Subjects: PRÓSTATA, NEOPLASIAS, SISTEMA IMUNE, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDOTTO, Thiago et al. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, v. 79, n. 9, p. 969-979, 2019Tradução . . Disponível em: https://doi.org/10.1002/pros.23808. Acesso em: 10 nov. 2024.
APA
Vidotto, T., Saggioro, F. P., Jamaspishvili, T., Chesca, D. L., Albuquerque, C. G. P. de, Reis, R. B. dos, et al. (2019). PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. The Prostate, 79( 9), 969-979. doi:10.1002/pros.23808
NLM
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1002/pros.23808
Vancouver
Vidotto T, Saggioro FP, Jamaspishvili T, Chesca DL, Albuquerque CGP de, Reis RB dos, Graham CH, Berman DM, Siemens DR, Squire JA, Koti M. PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells [Internet]. The Prostate. 2019 ; 79( 9): 969-979.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1002/pros.23808

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024